ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.726,76
-0,21%
S&P 500
5.316,65
0,16%
Dow Jones
39.858,35
0,13%
Euro vs US Dollar
1,08525
-0,07%
Bitcoin
69.694,57
-2,46%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Windtree Therapeutics Inc (WINT)

  7. Windtree Therapeutics Inc (WINT) News

WINT

Windtree Therapeutics (WINT)

Windtree Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:WINT
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202422h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WINTWindtree Therapeutics Inc
09/05/202414h41Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:WINTWindtree Therapeutics Inc
07/05/202414h00GlobeNewswire Inc.Windtree Therapeutics Regains Compliance with NasdaqNASDAQ:WINTWindtree Therapeutics Inc
18/04/202414h00GlobeNewswire Inc.Windtree Therapeutics Announces Reverse Stock SplitNASDAQ:WINTWindtree Therapeutics Inc
17/04/202414h00GlobeNewswire Inc.Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business UpdatesNASDAQ:WINTWindtree Therapeutics Inc
08/04/202422h48GlobeNewswire Inc.Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge FinancingNASDAQ:WINTWindtree Therapeutics Inc
16/02/202423h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WINTWindtree Therapeutics Inc
14/02/202423h23Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:WINTWindtree Therapeutics Inc
14/02/202422h30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:WINTWindtree Therapeutics Inc
14/02/202402h15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:WINTWindtree Therapeutics Inc
12/02/202422h40Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:WINTWindtree Therapeutics Inc
01/02/202423h26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:WINTWindtree Therapeutics Inc
01/02/202414h00GlobeNewswire Inc.Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a ResearchNASDAQ:WINTWindtree Therapeutics Inc
31/01/202414h40InvestorsHub NewsWireWindtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic AlternativesNASDAQ:WINTWindtree Therapeutics Inc
31/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WINTWindtree Therapeutics Inc
31/01/202414h00GlobeNewswire Inc.Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic AlternativesNASDAQ:WINTWindtree Therapeutics Inc
25/01/202415h04InvestorsHub NewsWireWindtree Eliminates $15 Million Contingent Liability to Deerfield Management CompanyNASDAQ:WINTWindtree Therapeutics Inc
25/01/202414h34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WINTWindtree Therapeutics Inc
25/01/202414h30GlobeNewswire Inc.Windtree Eliminates $15 Million Contingent Liability to Deerfield Management CompanyNASDAQ:WINTWindtree Therapeutics Inc
22/01/202422h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WINTWindtree Therapeutics Inc
17/01/202414h00GlobeNewswire Inc.Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific RegionNASDAQ:WINTWindtree Therapeutics Inc
17/01/202413h56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WINTWindtree Therapeutics Inc
16/01/202422h16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:WINTWindtree Therapeutics Inc
02/01/202422h05GlobeNewswire Inc.Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a ActivatorNASDAQ:WINTWindtree Therapeutics Inc
18/12/202314h00GlobeNewswire Inc.Windtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic ShockNASDAQ:WINTWindtree Therapeutics Inc
16/11/202314h00GlobeNewswire Inc.Windtree Therapeutics Announces Issuance of New Pure SERCA2a Activator PatentNASDAQ:WINTWindtree Therapeutics Inc
13/11/202317h41Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:WINTWindtree Therapeutics Inc
09/11/202322h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WINTWindtree Therapeutics Inc
09/11/202322h15GlobeNewswire Inc.Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business UpdatesNASDAQ:WINTWindtree Therapeutics Inc
09/11/202322h11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:WINTWindtree Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:WINT

Kürzlich von Ihnen besucht

CCOM
US500
US 500
NYSE
XOM
Exxon Mobil
TG
BAS
BASF
TG
RHM
Rheinmetall
AMEX
SPY
SPDR S&P 500
TG
DBK
Deutsche Bank
FX
EURGBP
Euro vs Sterling
TG
TUI1
Tui
TG
NOV
Novo Nordisk
NASDAQ
MSFT
Microsoft
COIN
BTCUSD
Bitcoin
FX
EURUSD
Euro vs US Dollar
NASDAQ
GOOGL
Alphabet
NASDAQ
NVDA
NVIDIA
TG
CBK
Commerzbank
TG
DTE
Deutsche Telekom
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten